A detailed history of Bailard, Inc. transactions in Boston Scientific Corp stock. As of the latest transaction made, Bailard, Inc. holds 203,755 shares of BSX stock, worth $18.6 Million. This represents 0.45% of its overall portfolio holdings.

Number of Shares
203,755
Previous 171,118 19.07%
Holding current value
$18.6 Million
Previous $13.2 Million 29.57%
% of portfolio
0.45%
Previous 0.37%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

BUY
$72.96 - $84.0 $2.38 Million - $2.74 Million
32,637 Added 19.07%
203,755 $17.1 Million
Q2 2024

Jul 25, 2024

BUY
$67.33 - $77.71 $1.08 Million - $1.25 Million
16,053 Added 10.35%
171,118 $13.2 Million
Q1 2024

May 08, 2024

BUY
$57.6 - $68.62 $1.81 Million - $2.16 Million
31,441 Added 25.43%
155,065 $10.6 Million
Q4 2023

Feb 02, 2024

BUY
$48.64 - $57.81 $6.01 Million - $7.15 Million
123,624 New
123,624 $7.15 Million

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $130B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Bailard, Inc. Portfolio

Follow Bailard, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bailard, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Bailard, Inc. with notifications on news.